Pharsight

Stiolto Respimat patents expiration

STIOLTO RESPIMAT's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
USRE39820 BOEHRINGER INGELHEIM Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
Jan, 2018

(6 years ago)

US7491719 BOEHRINGER INGELHEIM Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
Nov, 2023

(6 months ago)

US7056916 BOEHRINGER INGELHEIM Medicaments for the treatment of chronic obstructive pulmonary disease
Dec, 2023

(5 months ago)

US7220742 BOEHRINGER INGELHEIM Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
May, 2025

(11 months from now)

US7727984 BOEHRINGER INGELHEIM Medicaments for the treatment of chronic obstructive pulmonary disease
Jan, 2027

(2 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7246615 BOEHRINGER INGELHEIM Atomising nozzle and filter and spray generating device
May, 2016

(7 years ago)

US6176442 BOEHRINGER INGELHEIM Device for mounting a component exposed to a pressurized fluid
Oct, 2016

(7 years ago)

US5964416 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US7104470 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US6726124 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US6453795 BOEHRINGER INGELHEIM Locking mechanism for a spring-actuated device
Dec, 2016

(7 years ago)

US6149054 BOEHRINGER INGELHEIM Mechanical counter for a metering apparatus
Dec, 2016

(7 years ago)

US6149054

(Pediatric)

BOEHRINGER INGELHEIM Mechanical counter for a metering apparatus
Jun, 2017

(6 years ago)

US6846413 BOEHRINGER INGELHEIM Microstructured filter
Aug, 2018

(5 years ago)

US6977042 BOEHRINGER INGELHEIM Microstructured filter
Aug, 2018

(5 years ago)

US7802568 BOEHRINGER INGELHEIM Cartridge for a liquid
Feb, 2019

(5 years ago)

US6977042

(Pediatric)

BOEHRINGER INGELHEIM Microstructured filter
Feb, 2019

(5 years ago)

US6846413

(Pediatric)

BOEHRINGER INGELHEIM Microstructured filter
Feb, 2019

(5 years ago)

US7802568

(Pediatric)

BOEHRINGER INGELHEIM Cartridge for a liquid
Aug, 2019

(4 years ago)

US6988496 BOEHRINGER INGELHEIM Cartridge for a liquid
Feb, 2020

(4 years ago)

US6988496

(Pediatric)

BOEHRINGER INGELHEIM Cartridge for a liquid
Aug, 2020

(3 years ago)

US7988001 BOEHRINGER INGELHEIM Container provided with a pressure equalization opening
Aug, 2021

(2 years ago)

US8044046 BOEHRINGER INGELHEIM Medicaments for the treatment of chronic obstructive pulmonary disease
Nov, 2023

(6 months ago)

US7786111 BOEHRINGER INGELHEIM Medicaments for the treatment of chronic obstructive pulmonary disease
Nov, 2023

(6 months ago)

US7284474 BOEHRINGER INGELHEIM Piston-pumping system having o-ring seal properties
Aug, 2024

(3 months from now)

US7284474

(Pediatric)

BOEHRINGER INGELHEIM Piston-pumping system having o-ring seal properties
Feb, 2025

(9 months from now)

US8034809 BOEHRINGER INGELHEIM Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
May, 2025

(11 months from now)

US7896264 BOEHRINGER INGELHEIM Microstructured high pressure nozzle with built-in filter function
May, 2025

(1 year, 4 days from now)

US7396341 BOEHRINGER INGELHEIM Blocking device for a locking stressing mechanism having a spring-actuated output drive device
Oct, 2026

(2 years from now)

US9027967 BOEHRINGER INGELHEIM Device for clamping a fluidic component
Mar, 2027

(2 years from now)

US7396341

(Pediatric)

BOEHRINGER INGELHEIM Blocking device for a locking stressing mechanism having a spring-actuated output drive device
Apr, 2027

(2 years from now)

US7837235 BOEHRINGER INGELHEIM Device for clamping a fluidic component
Mar, 2028

(3 years from now)

US7837235

(Pediatric)

BOEHRINGER INGELHEIM Device for clamping a fluidic component
Sep, 2028

(4 years from now)

US8733341 BOEHRINGER INGELHEIM Atomizer and method of atomizing fluid with a nozzle rinsing mechanism
Oct, 2030

(6 years from now)

Stiolto Respimat is owned by Boehringer Ingelheim.

Stiolto Respimat contains Olodaterol Hydrochloride; Tiotropium Bromide.

Stiolto Respimat has a total of 34 drug patents out of which 22 drug patents have expired.

Expired drug patents of Stiolto Respimat are:

  • US7246615
  • US6176442
  • US5964416
  • US7104470
  • US6726124
  • US6453795
  • US6149054
  • US6149054*PED
  • US6846413
  • US6977042
  • US7802568
  • US6977042*PED
  • US6846413*PED
  • US7802568*PED
  • US6988496
  • US6988496*PED
  • US7988001
  • US8044046
  • US7786111
  • USRE39820
  • US7491719
  • US7056916

Stiolto Respimat was authorised for market use on 21 May, 2015.

Stiolto Respimat is available in spray, metered;inhalation dosage forms.

Stiolto Respimat can be used as treatment of copd, treatment of respiratory complaints.

Drug patent challenges can be filed against Stiolto Respimat from 31 July, 2018.

The generics of Stiolto Respimat are possible to be released after 16 October, 2030.

Drug Exclusivity Drug Exclusivity Expiration
M(M-233) Oct 05, 2021
New Combination(NC) May 21, 2018
New Chemical Entity Exclusivity(NCE) Jul 31, 2019
M(M-173) Mar 18, 2019

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE ingredient

NCE-1 date: 31 July, 2018

Market Authorisation Date: 21 May, 2015

Treatment: Treatment of copd; Treatment of respiratory complaints

Dosage: SPRAY, METERED;INHALATION

More Information on Dosage

STIOLTO RESPIMAT family patents

Family Patents